Abstract
Paclitaxel (PTX), a tetracyclic diterpenoid compound, is a broad-spectrum and highly effective antitumor drug. However, since it exhibited its complex chemical structure and low solubility, conventional PTX therapies are inefficient and even its solvent is toxic to humans. These drawbacks limited its wide application in cancer treatment. In contrast, PTX nano-delivery system has the advantages of high targeting and stability, which could significantly improve the solubility of PTX in water. The drug loading capacity is greatly increased due to prominent compatibility. By reviewing the relevant literature, this paper introduces several research directions of PTX drug delivery systems and lists the design applications of different nanocarriers in recent years. It also highlights the research progress of prodrugs and provides an outlook on its future directiont.
Publisher
Darcy & Roy Press Co. Ltd.
Reference30 articles.
1. Ezrahi S, Aserin A, Garti N. Basic principles of drug delivery systems-the case of paclitaxel [J]. Advances in Colloid and Interface Science, 2019, 263: 95 - 130.
2. Sharifi-rad J, Quispe C, Patra J K, et al. Paclitaxel: Application in Modern Oncology and Nanomedicine-Based Cancer Therapy [J]. Oxidative Medicine and Cellular Longevity, 2021, 2021: 3687700.
3. Zhou Zhuxian, Shen Youqing, Zhao Yuliang. Research and Frontiers in Nano-Drug Delivery Systems for Cancer Therapy [J]. China Basic Science, 2022, 24 (01): 25 - 36.
4. Yang Yanhua, Mao Jiawang, Tan Xiaoli. Research progress on the source, production, and anti-cancer mechanisms of paclitaxel [J]. Chinese Journal of Natural Medicines, 2020, 18 (12): 890 - 7.
5. Zhai Ruidong, Liu Zhepeng, Zhao Shoujin. Research progress in oral drug preparation of paclitaxel [J]. Practical Pharmacy and Clinical Remedies, 2022, 25 (01): 92 - 6.